Form 4: NeueHealth CEO George Lawrence Mikan III Reports Stock Transactions
SEC Form 4 Filing
George Lawrence Mikan III, CEO and President of NeueHealth, Inc., reported the disposition of 58,877 common stock shares on March 6, 2025, following the vesting of restricted stock units.
Summary
- On March 6, 2025, George Lawrence Mikan III, the CEO and President of NeueHealth, Inc., reported a transaction involving the company's stock.
- Mikan disposed of 58,877 shares of common stock.
- This transaction occurred due to the vesting of restricted stock units.
- Following the reported transaction, Mikan directly owns 205,416 shares of common stock.
- Mikan also directly owns 58,876 derivative securities.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, reporting a change in beneficial ownership. It doesn't inherently convey positive or negative sentiment.
Key Dates
| Date | Description |
|---|---|
| 03/06/2024 | Start date for vesting of restricted stock units in three equal annual installments |
| 03/06/2025 | Date of transaction: Disposition of 58,877 shares of common stock due to vesting of restricted stock units |
| 03/10/2025 | Date of signature for the report |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.